Cargando…

Two-decade change in prevalence of cognitive impairment in the UK

Identification of individuals at high risk of dementia has usually focused attention on the clinical concept of mild cognitive impairment (MCI), which captures an intermediate state between normal cognitive ageing and dementia. In many countries age specific risk of dementia has declined, but whethe...

Descripción completa

Detalles Bibliográficos
Autores principales: Richardson, Connor, Stephan, Blossom C. M., Robinson, Louise, Brayne, Carol, Matthews, Fiona E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Netherlands 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6861197/
https://www.ncbi.nlm.nih.gov/pubmed/31489532
http://dx.doi.org/10.1007/s10654-019-00554-x
_version_ 1783471300019224576
author Richardson, Connor
Stephan, Blossom C. M.
Robinson, Louise
Brayne, Carol
Matthews, Fiona E.
author_facet Richardson, Connor
Stephan, Blossom C. M.
Robinson, Louise
Brayne, Carol
Matthews, Fiona E.
author_sort Richardson, Connor
collection PubMed
description Identification of individuals at high risk of dementia has usually focused attention on the clinical concept of mild cognitive impairment (MCI), which captures an intermediate state between normal cognitive ageing and dementia. In many countries age specific risk of dementia has declined, but whether this is also the case for subclinical cognitive impairment is unknown. This has important implications for prevention, planning and policy. Here we describe subclinical cognitive impairment and mild dementia prevalence changes, in the UK, over 2 decades. The Cognitive Function and Ageing Studies have examined the full spectrum of cognition, from normal to dementia, in representative populations of people aged ≥ 65 years in the UK over the last 2 decades 7635 participants were interviewed in CFAS I in Cambridgeshire, Newcastle, and Nottingham in 1991, with 1457 being diagnostically assessed. In the same geographical areas, the CFAS II investigators interviewed 7796 individuals in 2011. Using established criteria, the population was categorised into seven groups: no cognitive impairment, Mild cognitive Impairment (defined using consensus criteria), other cognitive impairment no dementia without functional impairment, OCIND with functional impairment, cognitive impairment (MMSE < 24 and no functional impairment), mild dementia (MMSE < 24 with functional impairment, not captured by CFAS dementia criteria), and CFAS dementia criteria. Multinomial logistic regression, adjusted for age and sex, was used to estimate the prevalence of impairment in both studies. Results were standardized to the age-sex specific UK and global population. There is a clear increase in the prevalence of other cognitive Impairment no Dementia (without functional impairment), with the purer MCI remaining stable. In the UK, mild dementia is estimated to fall from 520,704 cases (5.7%, 95% CI 3.8, 8.1) in 1991 to 315,142 (3.0%, 95% CI 2.4, 3.8) in 2011, cognitive impairment, has fallen from 1,225,984 (13.5%, 95% CI 10.1, 17.5) to 654,436 (6.3%, 95% CI 5.4, 7.3) cases. Using additional categories which reflect the continuum of cognitive decline and impairment in populations we see that the mildest dementia declines, but that there is stability in estimates of those who meet MCI criteria. Increases were found in the Other Cognitive Impairment no Dementia group. The decline observed in severe impairment thus seems to have resulted in larger proportions of the population in milder forms, seen alongside physical illnesses. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s10654-019-00554-x) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-6861197
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Springer Netherlands
record_format MEDLINE/PubMed
spelling pubmed-68611972019-12-03 Two-decade change in prevalence of cognitive impairment in the UK Richardson, Connor Stephan, Blossom C. M. Robinson, Louise Brayne, Carol Matthews, Fiona E. Eur J Epidemiol Neuro-Epidemiology Identification of individuals at high risk of dementia has usually focused attention on the clinical concept of mild cognitive impairment (MCI), which captures an intermediate state between normal cognitive ageing and dementia. In many countries age specific risk of dementia has declined, but whether this is also the case for subclinical cognitive impairment is unknown. This has important implications for prevention, planning and policy. Here we describe subclinical cognitive impairment and mild dementia prevalence changes, in the UK, over 2 decades. The Cognitive Function and Ageing Studies have examined the full spectrum of cognition, from normal to dementia, in representative populations of people aged ≥ 65 years in the UK over the last 2 decades 7635 participants were interviewed in CFAS I in Cambridgeshire, Newcastle, and Nottingham in 1991, with 1457 being diagnostically assessed. In the same geographical areas, the CFAS II investigators interviewed 7796 individuals in 2011. Using established criteria, the population was categorised into seven groups: no cognitive impairment, Mild cognitive Impairment (defined using consensus criteria), other cognitive impairment no dementia without functional impairment, OCIND with functional impairment, cognitive impairment (MMSE < 24 and no functional impairment), mild dementia (MMSE < 24 with functional impairment, not captured by CFAS dementia criteria), and CFAS dementia criteria. Multinomial logistic regression, adjusted for age and sex, was used to estimate the prevalence of impairment in both studies. Results were standardized to the age-sex specific UK and global population. There is a clear increase in the prevalence of other cognitive Impairment no Dementia (without functional impairment), with the purer MCI remaining stable. In the UK, mild dementia is estimated to fall from 520,704 cases (5.7%, 95% CI 3.8, 8.1) in 1991 to 315,142 (3.0%, 95% CI 2.4, 3.8) in 2011, cognitive impairment, has fallen from 1,225,984 (13.5%, 95% CI 10.1, 17.5) to 654,436 (6.3%, 95% CI 5.4, 7.3) cases. Using additional categories which reflect the continuum of cognitive decline and impairment in populations we see that the mildest dementia declines, but that there is stability in estimates of those who meet MCI criteria. Increases were found in the Other Cognitive Impairment no Dementia group. The decline observed in severe impairment thus seems to have resulted in larger proportions of the population in milder forms, seen alongside physical illnesses. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s10654-019-00554-x) contains supplementary material, which is available to authorized users. Springer Netherlands 2019-09-05 2019 /pmc/articles/PMC6861197/ /pubmed/31489532 http://dx.doi.org/10.1007/s10654-019-00554-x Text en © The Author(s) 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Neuro-Epidemiology
Richardson, Connor
Stephan, Blossom C. M.
Robinson, Louise
Brayne, Carol
Matthews, Fiona E.
Two-decade change in prevalence of cognitive impairment in the UK
title Two-decade change in prevalence of cognitive impairment in the UK
title_full Two-decade change in prevalence of cognitive impairment in the UK
title_fullStr Two-decade change in prevalence of cognitive impairment in the UK
title_full_unstemmed Two-decade change in prevalence of cognitive impairment in the UK
title_short Two-decade change in prevalence of cognitive impairment in the UK
title_sort two-decade change in prevalence of cognitive impairment in the uk
topic Neuro-Epidemiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6861197/
https://www.ncbi.nlm.nih.gov/pubmed/31489532
http://dx.doi.org/10.1007/s10654-019-00554-x
work_keys_str_mv AT richardsonconnor twodecadechangeinprevalenceofcognitiveimpairmentintheuk
AT stephanblossomcm twodecadechangeinprevalenceofcognitiveimpairmentintheuk
AT robinsonlouise twodecadechangeinprevalenceofcognitiveimpairmentintheuk
AT braynecarol twodecadechangeinprevalenceofcognitiveimpairmentintheuk
AT matthewsfionae twodecadechangeinprevalenceofcognitiveimpairmentintheuk
AT twodecadechangeinprevalenceofcognitiveimpairmentintheuk